The document is a curriculum vitae for Dr. Rika Yuliwulandari that outlines her professional experience and qualifications. It details her educational background, including degrees from Universitas Airlangga and the University of Tokyo. It lists her professional roles, including Dean of the Faculty of Medicine at Universitas YARSI and head of the Genetics/Genomics Research Centre. It also outlines her research interests, awards, publications, editorial experience, and involvement in organizing scientific meetings.

1. Curriculum Vitae
Rika Yuliwulandari, MD, PhD
Universitas YARSI
1. Professional Interests
2. Professional Experience
3. Organization of Scientific Meetings
4. Awards & Achievement
5. Editorial Board Membership &
Reviewing Activity
6. Workshops, Training & Seminar
7. Research Projects/Grants
8. Book
9. Intellectual Property Right
10. Publications
11. Invited Speaker & Presentation
CONTENT

2. EDUCATIONAL INTERESTS:
1. Education of medical students, staff, nurses, and the public about pharmacology
RESEARCH INTERESTS:
1. Pharmacogenetics/pharmacogenomics and Ethnic Difference in Drug Response
2. Biomarkers for Personalized Pharmacotherapy
3. Drug Metabolism/Pharmacokinetics and Drug Interaction: from in vitro to in vivo
4. Drug Developmental Science – Early Phase Clinical Development
5. Data science and Bioinformatics
LICENSURE:
1. License to Practice Medicine in the Republic of Indonesia
EDUCATION:
Visiting Researcher Inje University, Korea Selatan as a part of World Class
Professor Program 2018
2018 Advisor: Professor Jae Gook Shin, MD, PhD
Post-doctoral Nuffield Department of Medicine, University of Oxford,
London, UK
2017 Advisor: Professor Adrian Hill
Rika Yuliwulandari, MD, PhD
Dean, Faculty of Medicine
Head of Genetics/Genomics Research Centre
Universitas YARSI
Jl. Letjen Suprapto, Cempaka Putih
Jakarta, Indonesia 10510
Mobile Phone: +62 877 8206 5501
Email: rika.yuliwulandari@yarsi.ac.id;
rika_yuliwulandari@yahoo.co.uk
H-Index: 9
I-10 Index: 10
Professional Interests

3. PhD Department of Human Genetics, Graduate School of Medicine, the
University of Tokyo, Japan
2008-2011 Advisor: Professor Katsushi Tokunaga
MSc Department of Human Genetics, Graduate School of Medicine,
the University of Tokyo, Japan
2006-2008 Advisor: Professor Katsushi Tokunaga
Undergraduate Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
1992-1999 Advisor: Professor DR. Dr. Arsiniati B. Arbai
2000 – Present : Lecturer, Department of Pharmacology Faculty of Medicine,
YARSI University
2001 – Present : Member, Indonesia Pharmacologist Association (IKAFI)
2002 – 2004 : Vice secretary, Indonesian Medical Association (IDI), East Jakarta
branch
2002 – 2005 : Vice Dean II for financial, administration and human resource
affairs,
Faculty of Medicine, YARSI University
2005 – 2007 : Secretary, Indonesian Medical Association (IDI), East Jakarta
branch
2009 – 2010 : Member, International Society of Human Genetics
2009 – 2010 : Member, American Society of Human Genetics (ASHG)
2010 – 2011 : Member, International Society for the Study of Xenobiotics (ISSX)
2011 – Present : Head of Genetic/Genomic Research Center, YARSI Research
Institute,
YARSI University
2011 – Present : Representative of Indonesia, South East Asian
Pharmacogenomics (SEAPHARM) consortium
Professional Experiences

4. 2013 – 2017 : Vice Rector II for Research and Publication, ex-officio Director of
YARSI
Research Institute, YARSI University
2013 – Present : Member, Indonesian Medical Association (IDI)
2013 – Present : Member, Research Ethic Committee Board, YARSI University
2014 – Present : Secretary, Research Ethic Committee Board, YARSI University
2013 – Present : Member, Academic Senate of YARSI University
2012 – Present : Chief, Education Monitoring and Evaluation Commission, Faculty
of
Medicine,YARSI University, Jakarta
2012 – Present : Representative of Indonesia, Global Genomic Medicine
Consortium
(G2MC)
2012 – Present : Representative of Indonesia, Mycobacterial Research Consortium
(MyRecon)
2014 – Present : Coordinator, Indonesian Pharmacogenomics Working Group
2015 – Present : Publication and Scientific Committee, Indonesian Pharmacologist
Association (IKAFI)
2016 – 2017 : Member, American Society of Human Genetics (ASHG)
2016 – 2017 : Member, International Society for the Study of Xenobiotics (ISSX)
2015 – Present : Drug Committee, Central Executive Board, The Indonesian
Medical
Association (PB IDI)
2015 – Present : Coordinator of Research in Indonesia Medical Forum (FOKI)
2017 – Present : Dean, Faculty of Medicine, YARSI University
2017 – Present : Member, Academic Senate, Faculty of Medicine, YARSI
University
2017 – Present : Chair, Faculty of Medicine Dean Forum

5. 2013 – 2017 : Chair of Annual seminar on research grant result
2014 : Chair of International Seminar and Workshop on Molecular
Medicine:
From Basic Science to Clinical Care 2014 and the 3rd
SeaPharm
Meeting
2015 : Chair of Internasional Seminar Yarsi Genomic Medicine
Conference 2015
2016 : Advisory committee of WorldAR 2016 Symposium
2016 : Advisory committee on International Halal Training
2016 : Member, International Conference of Herbal Medicine Committee
2017 : Member, Isolation Workshop of Herbal Medicine Committee
2017 : Chair of International Bioinformatics Workshop 2017
2017 : Steering Committee International Symposium of Bioinformatics
2017
2018 : Chair of International Bioinformatics Colloquium 2018
2018 : Chair of Bioinformatics Workshop Fiesta 2018
No Awards and Achievements Sponsor Institution Years
1 Asian Development Bank Scholarship ADB
2006-
2008
2 The Best Presenter in Thesis Defense The University of Tokyo 2008
3 3rd
Place in Scientific Paper Contest The University of Tokyo 2008
4 University of Tokyo Scholarship The University of Tokyo
2008-
2011
5
Wellcome Trust fellowships to attend
Advanced Course in Human Genome
Analysis: Genetic Analysis of Multifactorial
Diseases
Wellcome Trust 2009
Organization of Scientific Meetings
Awards & Achievements

6. 6
Finalist: I3L Life Science Award
Competition (national Level) I3L, Jakarta 2016
7
YARSI Researcher Award
The Best Young researcher in life science YARSI University 2017
8
Outstanding Lecturer Competition 2018 in
YARSI University YARSI University 2018
9
Outstanding Lecturer Competition 2018 in
LLDIKTI III LLDIKTI III 2018
10
Finalist: Outstanding Lecturer Competition
2018 (National Level)
2008 – Present : Editorial Board, Pharmamedica Journal
2012 - Present : Reviewer Board, Pharmamedika Journal
2013 – Present : Chief Editor, Jurnal Kedokteran YARSI (YARSI Medical Journal)
2013 – Present : Reviewer Board, Jurnal Kedokteran YARSI (YARSI Medical
Journal)
2013 – Present : Reviewer in National Accredited Journal “Universa Medicina”
2013 – Present : Reviewer Penelitian Internal Universitas YARSI grant
2013 – Present : Reviewer Penelitian Desentralisasi DIKTI grant
2016 : Reviewer International Journal “BMC Infectious Disease”
2017 : Reviewer International Journal “BMC Infectious Disease”
2017 – Present : Reviewer National Accredited DIKTI and KAN
2018 : Reviewer International Journal “BMJ case report Journal”
2018 : Reviewer Internasional Journal “Internasional Journal of Bio-X
Research”
2018 : Reviewer International Journal “International Journal of
Immunogenetics”
2018 : Reviewer International Journal “Drug Safety”
Editorial Boards Membership and Reviewing Activity

7. 2018 : Reviewer International Journal “ASEAN Journal of Community
Engagement”
2018 : Reviewer International Journal “The Indonesian Biomedical
Journal”
2019 : Reviewer International Journal : Journal of Clinical Pharmacy and
therapeutics”
2019 : Reviewer International Journal “BMJ Open”
Workshop & Trainings
No Activity Date
1
Workshop for Researcher PHK-PKPD, Faculty of
Medicine, YARSI University
14-15 Mei 2013
2
Workshop Common Techniques used in cell culture
and molecular biology
17-18 Mei 2013
3
Training “Applied Bio system 310 Genetic Analyzer
Training”
10 June 2013
4 Workshop for ISO 9001:2008 preparation 17 September 2013
5
Tarining “Dokumentasi Sistem Managemen Mutu
Laboratorium Kalibrasi / Pengujian : SNI ISO/IEC
17025:2008”
21 Mei 2014
6 Training for Making Research 14 July 2014
7
Workshop “Using software Mendeley for Reference
manager & Prezi for presentation
23 July 2014
8
Workshop How to Prepare an Online academic
journal? From human resources to digital data
19 August 2014
9
Workshop for SIMLITABMAS Reviewer to assess
proposal and research results
1 October 2014
10 CLC Genomics Workbench Training 30 July 2015
11
Workshop & Expose Science & Technology
Research Partnership for Sustainable Development
24 August 2015
12 TEIN4 Workshop on NGS and Big Data Analysis 26-28 August 2015
13
Training “Intensif E-jurnal Menggunakan Open
Jurnal System”
21-22 October 2015
14 International Training Auditor Halal 9-10 April 2016
15
Workshop Neuroscience Expert Tuition and How
To Write in Scientific Journal
16 August 2016
16
Workshop “Revitalisasi jejaring penelitian dan
pengembangan kesehatan nasional”
6-7 December 2016
Workshop, Trainings, & Seminar

8. 17
Workshop “Annual Meeting Forum Kedokteran
Indonesia (FOKI) 2017”
6-7 Mei 2017
18 Workshop The Introductory Bioinformatics 2017 6-14 March 2017
19 Applied Statistic Workshop 26 July 2017
20 Program Diploma Dokter Keluarga 2017
21 PEKERTI 2017
22 Pelatihan dan sertifikasi reviewer 2017
23
Program researcher link SAME ke Oxford
University
2017
24 Workshop Vaksinologi 2017
25
Bioinformatics Workshop Fiesta Essential Topics in
Bioinformatics: Beginner to Intermediate Level
23-27 April 2018
26
Bioinformatics Workshop Fiesta Computer
Programing in Bioinformatics
7-9 Mei 2018
27
Bioinformatics Workshop Fiesta Genome
Informatics
26-29 June 2018
28
Bioinformatics Workshop Fiesta Applied
Bioinformatics
9-13 July 2018
29
Bioinformatics Workshop Fiesta R for Practical
Data Analysis
27-31 August 2018
30
Bioinformatics Workshop Fiesta Applied Computing
for Bioinformatics
17-20 September 2018
31
Bioinformatics Workshop Fiesta Structural
Bioinformatics and Molecular Modelling
8-12 October 2018
32
Bioinformatics Workshop Fiesta Molecular
Mechanics and Docking
5-9 November 2018
33
Bioinformatics Workshop Fiesta Molecular
Dynamics and Simulation
3-7 December 2018

9. Seminar
No Activities Date
1 Participant in Celebrating 60 Years DNA Discovery 4 Juni 2012
2 Participant in XIV National IKAFI Congress 31 Oktober - 2 November 2013
3
Participant in International Seminar and Workshop
on Molecular Medicine: From Basic Science to
Clinical Care
15-16 April 2014
4
Participant in Seminar MassArray - a flexible and
powerful platform for genetic analysis
22 Oktober 2014
5
Participant in Seminar Peningkatan Pengetahuan
Praktis dan Sosialisasi Penyelesaian Sengketa
Medik, BPJS, Standar Kompetensi indonesia
13 Desember 2014
6
Participant in Symposium Translational in
Dermatology
7 Maret 2015
7
Participant in YARSI Genomic Medicine
Conference 2015
6-9 Mei 2015
8
Participant in World Academic and Research
Congress 2015
10 Desember 2015
9
Participant in Annual Meeting Forum Kedokteran
Indonesia (FOKI)
6 Mei 2016
10
Participant in “Rapat Koordinasi Lembaga
Penelitian & Pengabdian kepada Masyarakat dan
Badan Penelitan & Pengembangan”
9-10 Agustus 2016
11
Participant in International Conference of Herbal
Medicine
6-7 Oktober 2016
12
Participant in Annual Meeting of American Society
of Human Genetics
18-22 Oktober
13 Participant as a Merck-I3L Awards Finalist
14
Participant in Jakarta Meeting on Primary Care
Physician
14 Agustus 2017
15 Muktamar AIPKI IX 7-10 September 2017

10. 16
Seminar tantangan pendidikan tinggi di Era Digital
Disruption
5 Januari 2018
17 Seminar Penulisan Proposal Penelitian Unggulan 4-Sep-13
18
Seminar Infinite 200 Pro Series - Detection
Solution That Grow with Your Research Ideas
27 Januari 2014
19
Seminar hasil Penelitian dan Pengabdian
Masyarakat Hibah DIKTI dan Internal Universitas
YARSI Tahun 2015
27 Juni 2014
20
Seminar Emerging Contaminants Analysis
Ensuring Halal Food Integrity
25 Juni 2014
21 Seminar Luminex System 12 Agustus 2014
22
Seminar Analytical Solution in Halal Testing,
Herbal Research Proteomics and Metabolomics
14 Agustus 204
23
Workshop GC-MS: Gas Chromatography - Mass
Spectrophotometry for Alcohol / Product analysis
16 Desember 2014
24 Workshop FT-IR for Alcohol / Product Alcohol 16 Desember 2014
25 Pelatihan FT-IR 6-Apr-15
26
Lokakarya penyusunan dokumen paten dan
perlindungan atas hak kekayaan intelektual
28-Apr-18
27 Pelatihan GC-MS 8 Juni 2015
28 Pelatihan Reviewer 15 Juni 2015
29
Seminar Program Pendidikan Dokter Layanan
Primer dalam UU Pendidikan Kedokteran No 20
tahun 2013 dan Peranan Fakultas Kedokteran di
Indonesia
16 September 2015
30
Seminar hasil penelitian hibah DIKTI Universitas
YARSI tahun 2013/2014
30 Desember 2015
31
Seminar hasil penelitian hibah DIKTI Universitas
YARSI tahun 2014/2015
31 Desember 2015
32
Pelatihan penyusunan proposal bidang
pengabdian kepada masyarakat bagi para dosen
29 Maret 2016

11. No Year Reseach Title
Funding
Funder
Amount
(IDR)
1 2012-
2013
Studi Genomik Host dan Patogen
terhadap Timbulnya Multi Drug
Resistance Tuberkulosis
RISTEK DIKTI,
PUPT scheme
200.000.000
2 2013-
2015
Variabilitas Locus Gen Globin alfa
dan Beta serta HLA Kelas I dan II
pada Mahasiswa Kedokteran
Universitas YARSI: Inisiasi
Database Genomik Indonesia
Berbasis Web
RISTEK DIKTI,
PUPT scheme
200.000.000
3 2014-
2015
Pemetaan Variasi Gen NAT2 pada
Berbagai Kelompok Suku Bangsa
di Indonesia dan Pengembangan
Metode Genotyping NAT2 yang
Efisien untuk Skrining Hepatitis
Akibat Obat
RISTEK DIKTI,
Hibah Bersaing
scheme
75.000.000
4 2014-
2015
Association Study Multi Drug
Resistance Tuberkulosis (MDR-
TB) dan Anti Tuberculosis – Drug
Induce Liver Injury (AT-DILI)
RIKEN - Jepang 250.000.000
5 2014-
2015
Studi Adverse Drug Reaction pada
pasien epilepsi dan gangguan
syaraf lainnya
NIH - USA 150.000.000
6 2014-
2016
Pharmacoeconomics study for
Carbamazepine induce SJS/TEN
NIH - USA 150.000.000
7 2015-
2016
Studi Prediktor Suseptibilitas
Genetik Terhadap Penyakit Lepra
di Indonesia
RISTEK DIKTI,
PUPT scheme & GIS
- Singapore
200.000.000
Research Project and Grants

12. No Year Reseach Title
Funding
Funder
Amount
(IDR)
8 2015 -
2018
Investigasi Hubungan antara
Polimorfisme pada Daerah
Promoter Gen NAT2 dengan
Reaksi Hepatotoksisitas Akibat
Obat Anti-Tuberkulosis pada
Pasien Tuberkulosis di Indonesia
RISTEK DIKTI,
PUPT scheme
750.000.000
10 2017-
2018
Pengembangan kit skrining
SJS/TEN karena pengobatan
Carbamazepine pada pasien
epilepsi
RISTEK DIKTI,
National Competitive
Scheme
140.000.000
11 2019 -
Present
Pemetaan Dan Pengembangan
Database Hla-B Pada Etnis
Melayu Dan Bugis Di Indonesia
Untuk Menghindari Kejadian
Adverse Drug Reaction
RISTEK DIKTI,
PDUPT scheme
315.000.000
12 2019 -
Present
Pengembangan Algoritma Prediksi
Untuk Pengobatan Tuberkulosis
Berdasarkan Datgenomik Dan
Farmakokinetik Klinis
RISTEK DIKTI, Basic
Research scheme
315.000.000
13 2019 -
Present
Re-Sequencing Study of 1000
South East Asian Individuals
SEAPHARM,
Genetic Research
Center
In kind
1. Rika Yuliwulandari. Farmakogenomik & Farmakogenetik. Fakultas Kedokteran
Universitas YARSI, 2016; ix + 115 hlm.
2. Rika Yuliwulandari & Kinasih Prayuni. Chapter Book “ Bunga Rampai ForMind
2017”: Polimorfisme Gen N-Asetiltransferase 2 (NAT2) dan Implementasi
Farmakogenomik dalam Pengobatan Tuberkulosis, ITB Press, 2017: 309 hlm.
Books

13. 3. Rika Yuliwulandari, Hilyatuz Zahroh, Herman Usman, RW. Susilowati, Faradyna
Hendry. Mari Mengenal Lepra dan Menanggulangi Kusta. Fakultas Kedokteran
Universitas YARSI, 2018; 16 hlm.
4. Kinasih Prayuni, Qomariyah Sachrowardi, Rika Yuliwulandari. Chapter Book “
Bunga Rampai ForMind 2018”: Hubungan antara alel human leucocyte antigen
(HLA) dan hipersensitivitas terhadap obat, ITB Press, 2018: 314 hlm.
5. Rika Yuliwulandari, Qomariyah Sachrowardi, Kinasih Prayuni. Farmakogenomik
Obat Anti Tuberkulosis. Penerbit Buku Kedokteran EGC, 2019, viii + 99 hlm.
6. Rika Yuliwulandari, Qomariyah Sachrowardi, Kinasih Prayuni, Silviatun Nihayah.
Buku Praktis: Teknik Molekular Biologi di Bidang Kedokteran. Fakultas Kedokteran
YARSI, 2019, viii+54 hlm.
7. RW Susilowati, Kenconoviyati, Helwiah Umniati, Intan Razari, Kinasih Prayuni.
Editor: Rika Yuliwulandari. Database untuk penelitian genetik. Fakultas Kedokteran
YARSI, 2019, viii+60 hlm.
1. Copyright for Book “Farmakogenomik & Farmakogenetik” Registered No. 089387.
2. Copyright for Book “Mari Mengenal dan Menanggulangi Kusta” Registered No.
06608.
3. Copyright for Basic Data "Genomic Research Center in House Database"
Registered No. 000100080.
4. Copyright for Android Application “Leprosy Care” Registered No. 000113727.
5. Copyright for Book “Farmakogenomik Obat Anti Tuberkulosis” Registered No.
000132414.
6. Copyright for Book “Buku Praktis: Teknik Molekular Biologi di Bidang Kedokteran”
Registered No. 000132413.
7. Patent process for “Prototipe kit deteksi NAT2 asetilator lambat” No. Registration:
P00201708782.
8. Patent process for “Prototipe kit skriningi HLA-B*15:02 dan HLA-B*15:21” No.
Registration: P00201708783.
Intellectual Property Right

14. International Journal
1. Prayuni K, Razari I, Yuliwulandari R. Glutathione S-transferase M1 and T1 null
allele frequencies among Indonesian ethnics toward improved disease risk
assessment. Environmental Toxicology and Pharmacology. 2019;65:14-17.
2. Suvichapanich S, Fukunaga K, Zahroh H, Mushiroda T, Mahasirimongkol S, Toyo-
Oka L, Chaikledkaew U, Jittikoon J, Yuliwulandari R, Yanai H, Wattanapokayakit S,
Tokunaga K. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced
liver injury: a genotype-based meta-analysis. Pharmacogenetics and genomics.
2018; 28(7):167-176.
3. Manolio TA, Hutter CM, Avigan M, Cibotti R, Davis RL, Denny JC, Grenade LL,
Wheatley LM, Carrington MN, Chantratita W, Chung WH, Dalton AD, Hung SL, Lee
MTM, Leeder JS, Lertora JJL, Mahasirimongkol S, McLeod HL, Mockenhaupt M,
Pacanowski M, Phillips EJ, Pinheiro S, Pirmohamed M, Sung C, Suwankesawong
W, Trepanier L, Tumminia SJ, Veenstra D, Yuliwulandari R, Shear NH. Research
directions in genetic predispositions to Stevens–Johnson syndrome/toxic epidermal
necrolysis. Clinical Pharmacology & Therapeutics. 2018; 103(3): 390-394.
4. Yuliwulandari R, Kristin E, Prayuni K, Sachrowardi Q, Suyatna FD, Menaldi SL,
Wichukchinda N, Mahasirimongkol S, Cavallari LH. Association of HLA-B Alleles
with Carbamazepine-induced Steven Johnson syndrome/toxic epidermal necrolysis
in Javanese and Sundanese population of Indonesia: the important role of the HLA-
B75 serotype. Pharmacogenomics. 2017; 18(18): 1634-1648.
5. Yuliwulandari R, Prayuni K, Usman H, Sachrowardi Q, Tokunaga K. Differentiation
of N-acetyltransferase 2 (NAT2) rapid and intermediate acetylator based on
genotype and urinary assay. Australasian Medical Journal. 2017; 10(10): 879-883.
6. Yuliwulandari R, Diana NE, Prayuni K. The First Modular Database of Indonesian
Genes-Associated Diseases Information. Journal of Theoretical and Applied
Information Technology. 2017; 95(6): 1499-1058.
7. Nakauchi A, Wong JH, Mahasirimongkol S, Yanai H, Yuliwulandari R, Mabuchi A,
Liu X, Mushiroda T, Wattanapokayakit S, Miyagawa T, Keicho N. Identification of
Publications

15. ITPA on chromosome 20 as a susceptibility gene for young-onset tuberculosis.
Human Genome Variation. 2016 Feb 4;3: 15067.
8. Yuliwulandari R, Susilowati RW, Wicaksono BD, Viyati K, Prayuni K, Razari I,
Kristin E, Diana ES, Setiawati S, Ariyani A, Mahasirimongkol S. NAT2 variants are
associated with drug-induced liver injury caused by anti-tuberculosis drugs in
Indonesian patients with tuberculosis. Journal of human genetics. 2016 Feb 25;
61(6): 533-538.
9. Utomo CP, Kardiana A, and Yuliwulandari R. Breast Cancer diagnosis using
artificial neural networks with extreme learning technique. IJARAI 2014 3(7): 10-14
10. Mahasirimongkol S, Yanai H, Mushiroda T, Promphittayarat W, Wattanapokayakit S,
Phromjai J, Yuliwulandari R, Wichukchinda N, Yowang A, Yamada N, Kantipong P.
Genome-wide association studies of tuberculosis in Asians identify distinct at-risk
locus for young tuberculosis. Journal of human genetics. 2012 Jun 1;57(6):363-7.
11. Kobayashi K, Yuliwulandari R, Yanai H, Lien LT, Le Hang NT, Hijikata M, Keicho N,
Tokunaga K. Association of CD209 polymorphisms with tuberculosis in an
Indonesian population. Human immunology. 2011 Sep 30;72(9):741-5.
12. Yuliwulandari R, Sachrowardi Q, Nakajima H, Kashiwase K, Hirayasu K, Mabuchi
A, Sofro AS, Tokunaga K. Association of HLA-A,-B, and-DRB1 with pulmonary
tuberculosis in western Javanese Indonesia. Human immunology. 2010 Jul
31;71(7):697-701.
13. Yuliwulandari R, Okamoto K, Permana D, Tokunaga K. Effect of Promoter Region
Polymorphisms in N-Acetyltransferase 2 (NAT2) Phenotype. InDRUG
METABOLISM REVIEWS 2010 Aug 1 (Vol. 42, pp. 156-157). 325 CHESTNUT ST,
SUITE 800, PHILADELPHIA, PA 19106 USA: TAYLOR & FRANCIS INC.
14. Vollstedt S, Yuliwulandari R, Okamoto K, Lien LT, Keicho N, Rochani JT,
Wikaningrum R, Tokunaga K. No evidence for association between the interferon
regulatory factor 1 (IRF1) gene and clinical tuberculosis. Tuberculosis. 2009 Jan
31;89(1):71-6.
15. Fujimoto A, Nishida N, Kimura R, Miyagawa T, Yuliwulandari R, Batubara L,
Mustofa MS, Samakkarn U, Settheetham-Ishida W, Ishida T, Morishita Y. FGFR2 is
associated with hair thickness in Asian populations. Journal of human genetics.
2009 Aug 1;54(8):461-5.
16. Yuliwulandari R, Sachrowardi Q, Nishida N, Takasu M, Batubara L, Susmiarsih TP,
Rochani JT, Wikaningrum R, Miyashita R, Miyagawa T, Sofro AS. Polymorphisms of
promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in
the Indonesian population: proposal for a new nomenclature. Journal of human
genetics. 2008 Mar 1;53(3):201-9.
17. Fujimoto A, Kimura R, Ohashi J, Omi K, Yuliwulandari R, Batubara L, Mustofa MS,
Samakkarn U, Settheetham-Ishida W, Ishida T, Morishita Y. A scan for genetic

16. determinants of human hair morphology: EDAR is associated with Asian hair
thickness. Human molecular genetics. 2008 Mar 15;17(6):835-43.
National Journal
1. Soedarsono, Mandayani S, Prayuni K, Yuliwulandari R. The Risk Factors For Drug
Induced Hepatitis In Pulmonary Tuberculosis Patients In Dr. Soetomo Hospital.
Indonesian Journal of Tropical and Infectious Disease. 2018;7(3): 73-79.
2. Yuliwulandari R, Zahroh H, Susilowati RW, Hendri F, Usman H. Media Edukasi
Berbasis Cetak dan Digital tentang Pengobatan Lepra dan Efek Samping Obat
Mempermudah Pemahaman Penderita Lepra, Keluarga, Masyarakat, dan Tenaga
Kesehatan di Tanjung Pasir tentang Lepra dan Terapinya. Jurnal Pengabdian
kepada Masyarakat. 2017;3(1): 77-85.
3. Yuliwulandari R, Tokunaga K. Nasopharyngeal Carcinoma (NPC) Human
Leukocyte Antigen (HLA) Haplotype Sharing among Southern East Asian
Population. Global Medical and Health Communication: Journal of Medicine and
Health. 2017;5(1): 5-12.
4. Putri S, Rasmiyyah S, Huskany EA, Razari I, Wicaksono BD, Yuliwulandari R.
Relationship Between TNF-238G> A Polymorphism and Predisposition to Pulmonary
Tuberculois Infection in The Indonesian Population (A Pilot Study). Jurnal
Kedokteran YARSI. 2016 Jan 4;23(1):001-11.
5. Kenconoviyati K, Prayuni K, Susilowati RW, Yuliwulandari R, Sofro AS. Deteksi
Mutasi Langka, Delesi 619 bp, pada Gen Beta-Globin dari Etnis Melayu Mahasiswa
Fakultas Kedokteran Universitas YARSI. Jurnal Kedokteran YARSI. 2016 Jan
7;23(2):067-75.
6. Yuliwulandari R, Prayuni K, Kenconoviyati K, Susilowati RW, Sofro AS.
Pengembangan Metode In-House HLA-Typing Gen HLA Kelas I (HLA A, HLA B, dan
HLA C) Menggunakan Next Generation Sequencing Illumina MiSeq. Majalah
Kedokteran Bandung. 2015 Sep 29;47(3):152-9.
7. Prayuni K, Yuliwulandari, R. Next Generation Sequencing: Lintas Baru untuk
Proses Sequencing. YARSI Medical Journal. 2014;22(3):190-208.
8. Yuliwulandari R, Rochani JT, Indrawati I. Pengelompokan Genotip, Serologi dan
Supertipe Gene HLA Kelas I pada Suku Jawa, Indonesia. YARSI Medical Journal.
2010;18(2):086-93.

17. 1. Infectio “Current Updates on Infectious Disease”, Medicine Faculty, YARSI
University, Jakarta, 9 Desember 2018: Precision Medicine in Infectious Disease
(Invited Speaker).
2. Bioinformatics for NGS in Indonesia and the Application in Infectious Disease
Research (INARESPOND Seminar), Balitbangkes, Jakarta, 26 November 2018: A
Working with NGS in a Medical Research Laboratory (Invited Speaker).
3. Symposium: Updates and Clinical Implementation of Pharmacogenomics Towards
Precision Medicine, Rumah Sakit YARSI, Jakarta, 22 November 2018: Introduction
and Update Pharmacogenomic in the World and Indonesia (Incited Speaker).
4. The 7th
Southeast Asian Pharmacogenomics Meeting (SeaPharm), Singapore,
Singapore, 6-7 August 2018: Pharmacogenomics of AT-DILI in Indonesia (Invited
Speaker).
5. The 6th
Southeast Asian Pharmacogenomics Meeting (SeaPharm), Ho Chi Minh,
Vietnam, 17 August 2017: Pharmacogenomics of AT-DILI: Indonesian Updates
(Invited Speaker).
6. Innovative Intervention and Researches for END TB Strategy, Bangkok, Thailand,
15 November 2016: Pharmacogenetics of Anti-TB in Indonesia (Invited Speaker).
7. 2016 Annual Meeting of the American Society of Human Genetics, Vancouver,
Canada, 18-22 October 2016 (Poster Presentation).
8. The International Seminar on Global Strategy to Combat Emerging Infectious
Disease in Borderless Era (GSEID), Surabaya, 8 August 2016: Pharmacogenomics
and Clinical Implementation and Some Case Studies in Indonesia (Invited
Speaker).
9. The Trans-Academic Cancer Genetics (TACG) 2 Symposium and Workshop,
Yogyakarta, 19-21 August 2016: Pharmacogenomics and Pharmacogenetics in
Oncology (Invited Speaker).
10.The 5th
Southeast Asian Pharmacogenomics Meeting (SeaPharm), Bangkok, 14 July
2016: Pharmacogenomics of AT-DILI in Indonesia (Invited Speaker).
11.The 5th
Southeast Asian Pharmacogenomics Meeting (SeaPharm), Bangkok, 14 July
2016: Pharmacogenomics of SCAR in Indonesia (Invited Speaker).
12.The 5th
Southeast Asian Pharmacogenomics Meeting (SeaPharm), Bangkok, 14 July
2016: Cost Utility Analysis of genotyping HLA-B*15:02 to prevent Carbamazepine-
SJS/TEN in Indonesia (Invited Speaker).
13.World AR 2016, Jakarta, 10 December 2015: Detection of Thalassemia Carrier in
Malay ethnic of Medical Students, Universitas YARSI using Combination of
Polymerase Chain Reaction and Sanger Sequencing (Oral Presentation)
14.Golden Helix Symposium “Next Generation Pharmacogenomics”, Kuala Lumpur 11-
13 March 2015: Pharmacogenomics of Drug Induced Liver Injury due to Anti
Invited Speakers and Presentation

18. Tuberculosis Drugs and Indonesia Experience (Invited speaker).ICEPHH 2015,
Malang, 14-15 February 2015: NAT2 as a xenobiotic metabolyzing enzyme gene
and association with gene-environment diseases (Invited speaker).
15.Genetically Mediated Steven Johnsons Syndrome, NIH Bethesda Maryland 3-4
March 2015: Genetically-Mediated Stevens-Johnson Syndrome/Toxic Epidermal
Necrolysis Study, an Indonesia Case (Invited Speaker).
16.Tanslational in Dermatology, Jogjakarta, 7 March 2015: Pharmacogenomics of
Cutaneous Adverse Drug Reactions and the Potential Clinical Application (Invited
speaker).
17.YARSI Genomic Medicine Conference (YGMC), 3-4 Mei 2015: Reseach
Development in YARSI University (Invited Speaker).
18.Annual Meeting FOKI, Jogjakarta 14 June 2014: Genomics Research and
Development of Research Network (Invited speaker).
19.International Seminar and Workshop on Molecular Medicine, from Basic Science to
Clinical Care, Jakarta 15-16 April 2014: Functional Polymorphisms in the Promoter
and Coding Regions of NAT2 Gene (Invited speaker).
20.The 2nd
JSPS core to core meeting, Bangkok 31 July – 3 August 2013: NAT2 and
Drug Induced Hepatotoxicity (Invited speaker).
21.JSPS Kick off meeting JSPS core to core, 2-7 July 2012 Tokyo: HLA study in
Indonesia (Invited speaker).
22.The 1st
SEAPHARM meeting, 2-3 February 2012 (Bangkok): Pharmacogenomic
Studies in Indonesia (Invited speaker).
23.The 1st
USA-Indonesia Kavli Frontier of Science, 9-11 July 2011: Genetics Studies
of Tuberculosis in Indonesia (Invited speaker).
24.The 9th
International Meeting of International Society for the Study of Xenobiotics
(ISSX), 4-8 September 2010 (Istanbul, Turkey): N-Acetyltransferase 2 (NAT2)
phenotype in Indonesia (Poster presentation).
25.The 59th
Annual American Society of Human Genetics (ASHG) meeting, 22-25
October 2009 (Honolulu, Hawaii): Polymorphisms of Human Leukocyte Antigen
(HLA) gene and their association with tuberculosis in Western Indonesian (Poster
presentation).
26.The 84 Japanese Society of Tuberculosis (JST), 2-3 July 2009 (Hokkaido, Japan):
Host Genetic study of tuberculosis in Indonesian (Oral presentation).
27.The 17th
Annual Congress of the Japanese Society for Histocompatibility and
Immunogenetics (JSHI), 18-21 September 2008 (Osaka, Japan): Polymorphisms of
HLA genes in Western Javanese (Indonesia): close affinities to Southeast Asian
populations (Oral presentation).
28.The 53th
Annual Meeting of Japanese Society of Human Genetics (JSHG), 27-29
September 2008 (Tokyo, Japan): Polymorphisms of Human Leukocyte Antigen
(HLA) gene and their association with tuberculosis in Western Indonesian (Oral

19. presentation).
29.The 7th
International Workshop on Advance Genomics, 20 November 2007 (Tokyo,
Japan): Polymorphisms of Human Leukocyte Antigen (HLA) gene in Western
Indonesian (Oral presentation).
30.The 52th
Annual Meeting of Japanese Society of Human Genetics (JSHG), 13-15
September 2007 (Tokyo, Japan): Polymorphisms of NAT2 gene in Western
Javanese Indonesia (Oral presentation) (Oral presentation).
31.The 39th
Asia-Pacific Consortium of Public Health (APACPH) conference, 23-25
November 2007 (Saitama, Japan): Polymorphisms of promoter and coding regions
of the Arylamine N-Acetyltransferase 2 (NAT2) gene in the Indonesian population:
proposal for a new nomenclature (Poster presentation)